GF FUND MANAGEMENT CO. LTD. Q2 2025 Filing
Filed July 22, 2025
Portfolio Value
$5.0T
Holdings
660
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (660 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 601 | GLUEMonte Rosa Therapeutics Inc | 1,572 | $7.1M | 0.00% | |
| 602 | VNDAVanda Pharmaceuticals Inc | 1,493 | $7.0M | 0.00% | |
| 603 | ALTAltimmune Inc | 1,821 | $7.0M | 0.00% | |
| 604 | 0HQKCBL & Associates Properties In | 273 | $6.9M | 0.00% | |
| 605 | HUMAHumacyte Inc | 3,295 | $6.9M | 0.00% | |
| 606 | SLNSilence Therapeutics PLC | 1,165 | $6.8M | 0.00% | |
| 607 | RNACCartesian Therapeutics Inc | 650 | $6.8M | 0.00% | |
| 608 | TKNOAlpha Teknova Inc | 1,365 | $6.7M | 0.00% | |
| 609 | FHTXFoghorn Therapeutics Inc | 1,424 | $6.7M | 0.00% | |
| 610 | ANNXAnnexon Inc | 2,729 | $6.5M | 0.00% | |
| 611 | TRDAEntrada Therapeutics Inc | 958 | $6.4M | 0.00% | |
| 612 | CRVSCorvus Pharmaceuticals Inc | 1,594 | $6.4M | 0.00% | |
| 613 | INZYInozyme Pharma Inc | 1,544 | $6.2M | 0.00% | |
| 614 | THRDThird Harmonic Bio Inc | 1,118 | $6.1M | 0.00% | |
| 615 | ALLOAllogene Therapeutics Inc | 5,368 | $6.1M | 0.00% | |
| 616 | OLMAOlema Pharmaceuticals Inc | 1,422 | $6.1M | 0.00% | |
| 617 | ETREntergy Corp | 72 | $6.0M | 0.00% | |
| 618 | MXCTGBXMaxCyte Inc | 2,701 | $5.9M | 0.00% | |
| 619 | RCKTRocket Pharmaceuticals Inc | 2,333 | $5.7M | 0.00% | |
| 620 | NGNENeurogene Inc | 368 | $5.5M | 0.00% | |
| 621 | OABIOmniAb Inc | 3,099 | $5.4M | 0.00% | |
| 622 | TVGNTevogen Bio Holdings Inc | 4,207 | $5.3M | 0.00% | |
| 623 | INBXInhibrx Biosciences Inc | 359 | $5.1M | 0.00% | |
| 624 | YMABUSDY-mAbs Therapeutics Inc | 1,111 | $5.0M | 0.00% | |
| 625 | ACIUAC Immune SA | 2,454 | $5.0M | 0.00% | |
| 626 | ESPREsperion Therapeutics Inc | 5,045 | $5.0M | 0.00% | |
| 627 | CDXSCodexis Inc | 2,019 | $4.9M | 0.00% | |
| 628 | DSGNDesign Therapeutics Inc | 1,449 | $4.9M | 0.00% | |
| 629 | SLDBSolid Biosciences Inc | 991 | $4.8M | 0.00% | |
| 630 | SCPHscPharmaceuticals Inc | 1,242 | $4.7M | 0.00% | |
| 631 | CRGXCargo Therapeutics Inc | 1,142 | $4.7M | 0.00% | |
| 632 | EDITEditas Medicine Inc | 2,113 | $4.6M | 0.00% | |
| 633 | LRMRLarimar Therapeutics Inc | 1,583 | $4.6M | 0.00% | |
| 634 | OMEROmeros Corp | 1,483 | $4.4M | 0.00% | |
| 635 | FDMT4D Molecular Therapeutics Inc | 1,147 | $4.3M | 0.00% | |
| 636 | VYGRVoyager Therapeutics Inc | 1,355 | $4.2M | 0.00% | |
| 637 | ENTAEnanta Pharmaceuticals Inc | 525 | $4.0M | 0.00% | |
| 638 | CMPSCompass Pathways Plc | 1,261 | $3.5M | 0.00% | |
| 639 | ALECAlector Inc | 2,429 | $3.4M | 0.00% | |
| 640 | LXEOLexeo Therapeutics Inc | 820 | $3.3M | 0.00% | |
| 641 | KYTXKyverna Therapeutics Inc | 1,070 | $3.3M | 0.00% | |
| 642 | FATEFate Therapeutics Inc | 2,737 | $3.1M | 0.00% | |
| 643 | NKTXNkarta Inc | 1,751 | $2.9M | 0.00% | |
| 644 | IRWDIronwood Pharmaceuticals Inc | 3,971 | $2.8M | 0.00% | |
| 645 | NMRANeumora Therapeutics Inc | 3,883 | $2.8M | 0.00% | |
| 646 | CCCCC4 Therapeutics Inc | 1,751 | $2.5M | 0.00% | |
| 647 | CLYMClimb Bio Inc | 1,616 | $2.0M | 0.00% | |
| 648 | MGNXMacroGenics Inc | 1,557 | $1.9M | 0.00% | |
| 649 | TCRXTScan Therapeutics Inc | 1,218 | $1.8M | 0.00% | |
| 650 | PLRXPliant Therapeutics Inc | 1,509 | $1.8M | 0.00% | |
| 651 | BMEABiomea Fusion Inc | 899 | $1.6M | 0.00% | |
| 652 | PYXSPyxis Oncology Inc | 1,429 | $1.6M | 0.00% | |
| 653 | STROSutro Biopharma Inc | 1,982 | $1.4M | 0.00% | |
| 654 | ACRVAcrivon Therapeutics Inc | 772 | $919K | 0.00% | |
| 655 | ARTVArtiva Biotherapeutics Inc | 603 | $911K | 0.00% | |
| 656 | PEPGPepGen Inc | 808 | $897K | 0.00% | |
| 657 | 1K0IGM Biosciences Inc | 716 | $802K | 0.00% | |
| 658 | —Mersana Therapeutics Inc | 2,594 | $768K | 0.00% | |
| 659 | OKUROnKure Therapeutics Inc | 313 | $748K | 0.00% | |
| 660 | QTTBQ32 Bio Inc | 264 | $393K | 0.00% |
PreviousPage 7 of 7